Cite Filings / LXRX / 0001193125-26-034176
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13D/A

Beneficial Ownership Report

LEXICON PHARMACEUTICALS, INC. · Filed 2026-02-02 · Acc 0001193125-26-034176

Documents 1

  • SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2026-05-08 SCHEDULE 13D/A Beneficial Ownership Report
  • 2026-02-04 4 Director bought 1,538,462 shares at $1.30 ($2,000,001)
  • 2026-02-02 SCHEDULE 13D/A Beneficial Ownership Report
  • 2026-02-02 8-K Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
  • 2026-02-02 424B5 Prospectus
  • 2026-01-30 FWP Free Writing Prospectus
  • 2026-01-30 FWP Free Writing Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…